Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00462839 · ClinicalTrials.gov registry record · NA

Accuracy of Blood Loss Estimation After Vaginal Delivery

A NA study, sponsored by Northwestern University.

Completed
Registry status
NA
Development phase
106
Enrollment target

NCT00462839 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 106 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00462839, a NA study, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
NA
Development phase
106 participants
Enrollment target

Study Summary

Post-partum hemorrhage (PPH) is defined as blood loss greater than 500 mL after vaginal delivery. Delayed diagnosis of PPH is a major cause of maternal morbidity and mortality. Obstetricians estimate blood loss at delivery by visual estimation of blood collected in the obstetric drapes. Blood is often mixed with urine and surgical sponges. The urine, blood, and sponges collect in a cone shaped plastic bag that is suspended from the perineum during delivery. Visual estimation of blood loss is insensitive in diagnosing PPH. In one study visual assessment of blood loss underestimated postpartum blood loss by 33% to 50% compared to an objective measurement of blood loss using photospectrometry. Other studies have shown that the magnitude of underestimation increases as the amount of blood loss is increased. A limitation of previous studies is that there is no "gold standard" for blood loss determination in the third stage of labor. Care providers (obstetricians, anesthesiologists, and labor \& delivery nurses) need to be able to accurately estimate blood loss in order to better care for mothers and prevent morbidity and mortality. It is unknown whether provider type or experience (obstetric and anesthesiology resident, fellow, attending physicians, and nurses) influences the accuracy of blood loss estimation, or whether blood loss estimation can be improved by providing graduated markings on the vaginal delivery drape.

Interventions

  • PROCEDURE blood loss estimation

Trial Details

FieldValue
Enrollment Target 106 participants
Start Date 2006-07
Est. Completion 2008-04
Phase NA

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT00462839

The ClinicalTrials.gov registry entry for NCT00462839 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which blood loss estimation is the first listed.

NCT00462839 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00462839 about?

NCT00462839 is a clinical study titled "Accuracy of Blood Loss Estimation After Vaginal Delivery". Post-partum hemorrhage (PPH) is defined as blood loss greater than 500 mL after vaginal delivery. Delayed diagnosis of PPH is a major cause of maternal morbidity and mortality. Obstetricians estimate blood loss at delivery by visual estimation of blood collected in the obstetric drapes. Blood is oft...

What is the current status of trial NCT00462839?

This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2006-07. Estimated completion is 2008-04.

What interventions are being tested in trial NCT00462839?

The interventions under investigation include: blood loss estimation (PROCEDURE).

Who is sponsoring clinical trial NCT00462839?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.